John Cummins, M.P.
Delta-South Richmond
News Release

FOR IMMEDIATE RELEASE
June 20, 1995

 

DELTA M.P. CRITICIZES SOMALIA COMMISSION OF INQUIRY
FOR DENIAL OF APPLICATION TO APPEAR

OTTAWA--- Delta M.P. John Cummins today criticized the Commission of Inquiry into the Deployment of Canadian Forces to Somalia for denying his application to appear before the Commission.

Cummins applied to appear before the Commission on June 7th in order to present information and evidence to the Commission concerning the use of the anti-malaria drug mefloquine by Canadian Forces personnel in Somalia and its relevance in the case of Kyle Brown. Yesterday Cummins was advised by Commission Counsel that his application had been denied.

The Delta M.P. has been a longstanding vocal advocate of a full, public inquiry into the Canadian mission in Somalia. While the Commission acknowledged that Cummins may have information "which may be helpful to the Commission," they recommended that he present his information to Commission Counsel who would "review it for its relevancy" and then determine whether to file "all, part or any of that information with the Commission."

"I find it unacceptable that Commission Counsel wants to edit my presentation to the Commission," said Cummins. "Such actions border on censorship." "if I, as a Member of Parliament with information relevant to this Inquiry, have been denied the opportunity to appear, it raises questions in my mind about the credibility of the entire process," continued the M.P.

"Based on my investigation, I believe that the role of mefloquine in the Somalia mission is of tremendous significance," said the M.P. "Its neuropsychiatric effects have been well-documented," he added. "Without an open and public inquiry, Canadians will be denied the opportunity to assess the relevance of mefloquine for themselves," he stressed. "The interests of justice demand nothing less," he concluded.

-30-

For more information, please contact:

John Cummins, M.P.
(604) 940-8040 or 970-0937 (cell)